CR8695A - Preparado polifasico para la contracepcion a base de un estrogeno natural - Google Patents

Preparado polifasico para la contracepcion a base de un estrogeno natural

Info

Publication number
CR8695A
CR8695A CR8695A CR8695A CR8695A CR 8695 A CR8695 A CR 8695A CR 8695 A CR8695 A CR 8695A CR 8695 A CR8695 A CR 8695A CR 8695 A CR8695 A CR 8695A
Authority
CR
Costa Rica
Prior art keywords
natural
strogen
polyphasic
preparation
contraception based
Prior art date
Application number
CR8695A
Other languages
English (en)
Inventor
Jan Endrikat
Bernd Dusterberg
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR8695(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR8695A publication Critical patent/CR8695A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La invencion se refiere a un preparado polifasico para la contracepcion a base de un estrogeno natural en combinacion con un gestageno sintetico que asegura mayor seguridad contraceptiva durante todo el ciclo, que mejora el comportamiento ciclico de la hemorragia y minimiza o elimina los efectos secundarios tales como tension en los pechos, dolores de cabeza, estados de animo depresivos y modificaciones de la libido, etc. en comparacion con los contraceptivos anovulatorios tradicionales del mismo tipo.
CR8695A 2004-04-20 2006-10-19 Preparado polifasico para la contracepcion a base de un estrogeno natural CR8695A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004019743A DE102004019743B4 (de) 2004-04-20 2004-04-20 Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens

Publications (1)

Publication Number Publication Date
CR8695A true CR8695A (es) 2008-07-29

Family

ID=34979546

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8695A CR8695A (es) 2004-04-20 2006-10-19 Preparado polifasico para la contracepcion a base de un estrogeno natural

Country Status (37)

Country Link
US (3) US8071577B2 (es)
EP (1) EP1740163B2 (es)
JP (1) JP4908399B2 (es)
KR (1) KR20060134168A (es)
CN (1) CN1946383B (es)
AR (2) AR048830A1 (es)
AT (1) ATE473734T1 (es)
AU (1) AU2005235418C1 (es)
BR (1) BRPI0510005A (es)
CA (1) CA2561839C (es)
CR (1) CR8695A (es)
CY (1) CY1111292T1 (es)
DE (2) DE102004019743B4 (es)
DK (1) DK1740163T4 (es)
EA (1) EA010313B1 (es)
EC (1) ECSP067000A (es)
ES (1) ES2348038T5 (es)
GT (1) GT200500093A (es)
HR (1) HRP20100513T4 (es)
IL (2) IL178510A (es)
ME (1) ME01183B (es)
MX (1) MXPA06012213A (es)
MY (1) MY143669A (es)
NO (1) NO344098B1 (es)
NZ (1) NZ550417A (es)
PA (1) PA8630901A1 (es)
PE (1) PE20060308A1 (es)
PL (1) PL1740163T5 (es)
PT (1) PT1740163E (es)
RS (1) RS51434B2 (es)
SI (1) SI1740163T2 (es)
SV (1) SV2006002090A (es)
TW (1) TWI351960B (es)
UA (1) UA83915C2 (es)
UY (1) UY28863A1 (es)
WO (1) WO2005102247A2 (es)
ZA (1) ZA200609594B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
PT1937274E (pt) * 2005-10-13 2012-05-28 Bayer Pharma AG Utilização de valerato de estradiol em combinação com dienogest para a terapia oral da hemorragia uterina disfuncional em conjunto com uma contracepção oral
PT1787649E (pt) * 2005-10-13 2009-05-08 Bayer Schering Pharma Ag Utilização de valerato de estradiol em combinação com dienogest para a terapia oral da hemorragia uterina disfuncional em conjunto com uma contracepção oral
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
MX2008011074A (es) 2006-03-02 2008-09-10 Warner Chilcott Co Inc Metodo anticonceptivo oral multifasico de ciclo prolongado.
DE102006010329A1 (de) * 2006-03-06 2007-09-13 Höltge, Michael, Dipl.-Med. Hormonelles Kontrazeptivum auf der Basis eines Estrogens, eines Gestagens oder einer Kombination von Estrogenen und Gestagenen unter der Zugabe von Testosteron
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US20090117183A1 (en) * 2007-11-05 2009-05-07 Sabine Fricke Oral contraceptive containing a gestagen and an estrogen combined with pharmaceutically acceptable auxiliary agents and/or excipients, but not containing lactose, and method of making same
TW201306825A (zh) * 2011-05-11 2013-02-16 Kirax Corp 狀況治療之改良套裝

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4168068A (en) 1969-07-22 1971-01-28 Unisearch Limited Improvements in or relating to oral contraceptives
US3639600A (en) 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3795734A (en) 1970-04-20 1974-03-05 American Home Prod Cyclic regimen of hormone administration for contraception
US4066757A (en) 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
DE2365103C3 (de) 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
DE2431704A1 (de) 1974-07-02 1976-01-22 Asche Ag Stufenkombinationspraeparate per kontrazeption
DE2645307A1 (de) 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
JPS6019734B2 (ja) 1977-05-12 1985-05-17 三共株式会社 安定なプロスタグランジンｅ類製剤の製法
US4272270A (en) 1979-04-04 1981-06-09 Petrochem Consultants, Inc. Cryogenic recovery of liquid hydrocarbons from hydrogen-rich
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4530839A (en) 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4544554A (en) 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3341638A1 (de) 1983-11-17 1984-05-03 Hermann Dr.rer.nat. 8000 München Heßlinger Dreiphasen-praeparat zur empfaengnisverhuetung aus ethinyloestradiol und lynestrenol
DE3347125A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
AU581486B2 (en) 1985-12-30 1989-02-23 Warner-Lambert Company Graduated estrogen contraceptive
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
CA2005933A1 (en) 1989-01-09 1990-07-09 Jesse Hipps, Sr. Photohardenable composition containing five member aromatic group with imine moiety
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4104385C1 (es) 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4224534A1 (de) 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
DE4313926A1 (de) * 1993-04-28 1994-11-03 Jenapharm Gmbh Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
DE4339934C2 (de) 1993-05-07 1995-05-24 Klaus Dr Med Umbreit Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl) 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4429374C1 (de) 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US20050032756A1 (en) 1995-10-28 2005-02-10 Michael Dittgen Multistage preparation for contraception based on natural estrogens
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE69724796T2 (de) 1996-07-26 2004-07-01 Wyeth Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
WO1998004269A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
WO1998004268A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Oral contraceptive
US6987101B1 (en) 1996-12-20 2006-01-17 Schering Aktiengesellschaft Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
DE19654609A1 (de) 1996-12-20 1998-06-25 Schering Ag Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6312772B1 (en) * 1997-10-20 2001-11-06 Hoechst Celanese Corporation Multilayer laminate formed from a substantially stretched non-molten wholly aromatic liquid crystalline polymer and non-polyester thermoplastic polymer
DE19908762A1 (de) * 1999-02-18 2000-08-31 Jenapharm Gmbh Verwendung von Dienogest in hoher Dosierung
DE10045380A1 (de) 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US6699820B2 (en) 2001-03-02 2004-03-02 Hartmut Ulrich Bielefeldt Method for making a superconductor with enhanced current carrying capability
WO2003028735A1 (de) 2001-09-29 2003-04-10 Solvay Pharmaceuticals Gmbh Estrogen-gestagen kombinationspräparat und anwendung
EP1462106A1 (en) 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
JP2007528358A (ja) * 2003-06-25 2007-10-11 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ジエノゲストを含んでなるホルモン置換療法および抑鬱療法
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
EP2392332A1 (en) 2004-10-07 2011-12-07 Teva Women's Health, Inc. Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
TW200726473A (en) 2005-06-28 2007-07-16 Wyeth Corp Compositions and methods for treatment of cycle-related symptoms
PT1787649E (pt) 2005-10-13 2009-05-08 Bayer Schering Pharma Ag Utilização de valerato de estradiol em combinação com dienogest para a terapia oral da hemorragia uterina disfuncional em conjunto com uma contracepção oral
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Also Published As

Publication number Publication date
IL239861A0 (en) 2015-08-31
EP1740163B1 (de) 2010-07-14
DE102004019743B4 (de) 2008-11-27
CN1946383B (zh) 2010-06-09
BRPI0510005A (pt) 2007-09-18
PE20060308A1 (es) 2006-05-25
MXPA06012213A (es) 2007-01-17
CN1946383A (zh) 2007-04-11
JP4908399B2 (ja) 2012-04-04
SI1740163T2 (sl) 2020-04-30
DK1740163T4 (da) 2020-04-06
DE502005009904D1 (de) 2010-08-26
EP1740163A2 (de) 2007-01-10
ECSP067000A (es) 2006-12-29
EA010313B1 (ru) 2008-08-29
NZ550417A (en) 2010-01-29
UY28863A1 (es) 2005-11-30
PL1740163T5 (pl) 2020-10-05
US20110124612A1 (en) 2011-05-26
AR084229A2 (es) 2013-05-02
RS51434B2 (sr) 2020-11-30
RS51434B (sr) 2011-04-30
NO344098B1 (no) 2019-09-02
WO2005102247A2 (de) 2005-11-03
IL178510A (en) 2015-08-31
SV2006002090A (es) 2006-02-15
UA83915C2 (ru) 2008-08-26
EA200601844A1 (ru) 2007-04-27
CY1111292T1 (el) 2015-08-05
US20070259840A1 (en) 2007-11-08
ATE473734T1 (de) 2010-07-15
NO20065292L (no) 2007-01-17
ES2348038T3 (es) 2010-11-29
AU2005235418A1 (en) 2005-11-03
AU2005235418C1 (en) 2015-05-21
JP2007533681A (ja) 2007-11-22
DE102004019743A1 (de) 2005-11-24
DK1740163T3 (da) 2010-10-18
ES2348038T5 (es) 2020-09-14
ME01183B (me) 2013-03-20
IL178510A0 (en) 2007-02-11
US8071577B2 (en) 2011-12-06
AR048830A1 (es) 2006-05-31
KR20060134168A (ko) 2006-12-27
CA2561839C (en) 2009-09-29
WO2005102247A3 (de) 2006-01-12
TWI351960B (en) 2011-11-11
US20100173877A1 (en) 2010-07-08
PA8630901A1 (es) 2006-05-16
GT200500093A (es) 2006-04-17
HRP20100513T4 (hr) 2020-10-02
PT1740163E (pt) 2010-09-28
HK1099701A1 (zh) 2007-08-24
EP1740163B2 (de) 2020-01-15
HRP20100513T1 (hr) 2010-11-30
MY143669A (en) 2011-06-30
ZA200609594B (en) 2008-04-30
PL1740163T3 (pl) 2010-12-31
SI1740163T1 (sl) 2010-11-30
AU2005235418B2 (en) 2009-08-06
TW200534860A (en) 2005-11-01
CA2561839A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
CR8695A (es) Preparado polifasico para la contracepcion a base de un estrogeno natural
CR10528A (es) Proceso para producir poxvirus y composiciones de poxvirus
BR112017011148A2 (pt) composição de borracha, método para produção da mesma, e pneu
HN2003000094A (es) Indazoles subtituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
HN2008000188A (es) 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
AR058820A1 (es) Cable que tiene propiedades autoextinguibles con baja emision de humo y composicion retardante de llamas usadas en el mismo
BR112014008580A2 (pt) dissociador de isolamento do alternador
PE20150305A1 (es) Unidad de ajuste para banda de soporte de casco protector, particularmente para trabajadores forestales
MX2015015264A (es) Composiciones y metodos para modular la expresion de ttr y vhb.
EA201070555A1 (ru) Полотенце, пригодное для носки
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
PA8604401A1 (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
UY3985Q (es) Paquete de cigarillos simulado
GT200400257A (es) Composicion herbicida
UY29248A1 (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
CR8617A (es) Formulaciones de dispersiones solidas de acetato de bazedoxifeno
SV2003001082A (es) Microcapsulas para la proteccion frente al mal aliento
CU20060197A7 (es) Preparado polifásico para la contracepción a base de un estrógeno natural
MX2024006489A (es) Producto cosmetico en barra, empaquetado.
UY30368A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion
CR9115A (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
CR10390A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparacion, composiciones que las contienen y utilizacion
TR200803583U (tr) Esneyen/sünen boyun bölümüyle değiştirilebilen kravat kuyruğu.
RU2008105058A (ru) Упругодеформируемый схват
PL124154U1 (pl) Mechanizm połączenia rozłącznego korpusu urządzenia, zwłaszcza nadawczo-odbiorczego z korpusem zasilacza